Academy of Military Medical Sciences
The Academy of Military Medical Sciences of the PLA Academy of Military Science is a Chinese military medical research institute. It was established in Shanghai in 1951. It has been based in Beijing since 1958.
In October 2011 the drug "Night Eagle", developed to help soldiers cope with sleep deprivation during missions, was unveiled in an exhibition marking the institute's 60th anniversary.
In December 2014, the Chinese government announced that the Academy of Military Medical Sciences had developed an Ebola virus vaccine candidate that had been approved for clinical trials.During the COVID-19 Pandemic, the AMMS has partnered with CanSino Biologics to develop a COVID-19 vaccine. The vaccine jointly developed by them was the first one approved outside of clinical trials in an expedite decision that authorized its used only by the chinese military.
